Clinical Trials Directory

Trials / Completed

CompletedNCT02026882

Supreme LMA Use in Urgent Caesarean Section

Supreme Laryngeal Mask Use in Urgent Caesarean Section

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
584 (actual)
Sponsor
QuanZhou Women and Children's Hospital · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The Supreme Laryngeal Mask Airway (SLMA) is a single use supraglottic device that provides a good seal for positive pressure ventilation and good first attempt insertion rate of 98% in low risk patients undergoing elective Caesarean section. It has a double aperture design that facilitates the introduction of an orogastric tube to aspirate gastric contents. The primary study hypothesis is the first attempt insertion success rate of SLMA use in urgent Caesarean section.

Detailed description

Investigators propose a prospective cohort study to study the first attempt insertion success rate of supreme LMA in general anaesthesia for urgent caesarean section.

Conditions

Interventions

TypeNameDescription
DEVICESupreme Laryngeal Mask AirwaySupreme Laryngeal Mask Airway. Preoxygenation, rapid sequence induction and cricoid pressure. Induction of general anaesthesia.

Timeline

Start date
2013-12-01
Primary completion
2014-12-01
Completion
2015-05-01
First posted
2014-01-03
Last updated
2020-08-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02026882. Inclusion in this directory is not an endorsement.